FDA Inspection 1072981 — LifeServe Blood Center

LifeServe Blood Center — FEI 3003294564

The FDA completed an inspection of LifeServe Blood Center on Oct 23, 2018 in Marshalltown, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Oct 23, 2018
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Marshalltown, IA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.